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Abstract 
Prescription drug abuse has become a top public health concern in the United States in 
recent years.  Changes in prescribing practices and the way in which health providers manage 
pain resulted from national quality improvement efforts in the 1990s.  The majority of efforts to 
reduce morbidity and mortality associated with the prescription drug abuse epidemic occur 
through policy initiatives at the state level.  In 2011, Indiana ranked 17th in the U.S. and had only 
implemented a few intervention and prevention strategies.  However, through a coordinated 
effort within the state, Indiana has expanded Good Samaritan laws and adopted rescue drug 
policies.  Furthermore, the nursing workforce in Indiana has played a critical role in the 
successful implementation of these new policies.  Nurses across the state have provided 
education and training to first responders and lay persons.  They have also consulted with law 
enforcement agencies and other organizations looking to fully leverage the potential of these new 
state policies.  As a result of their versatility and clinical expertise the nursing workforce has and 
will continue to play a critical role in the successful implementation of state policy initiatives 
aimed at fighting the prescription drug abuse epidemic.  
Keywords: prescription drug abuse, nursing, nursing workforce, opioids, opioid 
analgesics, state policy, health policy, public health 
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Fighting Prescription Drug Abuse through State Policy:  
The Role of Nursing in Successful Implementation 
Introduction 
In 2009, the United Nations Office on Drugs and Crime (UNODC) estimated that 
between 12 and 21 million people used opiates worldwide (United Nations Office on Drugs and 
Crime, 2014).  “Opiates and opioids top the list of problem drugs that cause the most burden of 
disease and drug-related deaths worldwide.  In recent years, the non-medical use of various 
prescription opioids has become increasingly problematic in some areas of the world, 
particularly in North America”(United Nations Office on Drugs and Crime, 2014). The United 
States has been a victim of the prescription drug abuse epidemic.  Today, emergency 
departments (ED) in the U.S. are flooded with treatment admissions related to prescription 
opioid use. Between 1993 and 2005, opioid prescribing for pain-related visits to the ED 
increased by 14% (Pletcher, Kertesz, Kohn, & Gonzales, 2008).  This prescribing trend increased 
after national quality improvement initiatives in the late 1990s (Pletcher et al., 2008). 
In 2012, the U.S. Centers for Disease Control and Prevention (CDC) estimated that 
someone dies from an unintentional prescription drug overdose every 19 minutes (Centers for 
Disease Control and Prevention, 2012b).  Overdoses from prescription opioid pain relievers 
(OPR) quadrupled between 1999 and 2010 (Rudd et al., 2014).  An analysis of mortality data 
from 28 states showed that from 2010 to 2012 heroin overdoses increased from 1.0 to 2.1 per 
100,000 people whereas the death rate for OPR overdoses decreased from 6.0 to 5.6 during the 
same period (Rudd et al., 2014).  Although the OPR overdose death rate decreased during this 
time period, it remains a significant problem throughout the United States. 
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A major contributing factor to the increase in the unintentional drug overdose death rate 
in recent years is the expanded use of opioid analgesics. Over the past decade opioid analgesics 
have caused more overdose deaths than heroin and cocaine combined (Centers for Disease 
Control and Prevention, 2012a). If the number of deaths related to prescription drug abuse is not 
alarming enough, the CDC reports that for every unintentional overdose, “nine persons are 
admitted for substance abuse treatment, 35 visit emergency departments, 161 report drug abuse 
or dependence, and 461 report nonmedical uses of opioid analgesics” (Centers for Disease 
Control and Prevention, 2012b).  
Cost of the Problem 
Not only are the number of deaths related to prescription drug abuse alarming, but the 
economic impact of opioid abuse represents a significant burden for society. In 2006, a study 
estimated that the cost to the U.S. economy for nonmedical use of prescription painkillers was 
$53.4 billion.  Of that, $42 billion was due to lost productivity, $8.2 billion in criminal justice 
costs, $2.2 billion for drug abuse treatment, and $944 million in medical complications (Hansen, 
Oster, Edelsberg, Woody, & Sullivan, 2011).  Figure 1 illustrates the breakdown of these costs. 
In addition to these costs, fraudulent or abusive purchases of controlled substances has resulted 
in high costs to the U.S. Medicaid program, according to the Government Accountability Office 
(Levi, Segal, & Miller, 2013).  
As a result of the increasing rate of fatalities due to drug overdoses and the significant 
economic burden associated with these mortalities the White House Office of National Drug 
Control Policy (ONDCP), the Centers for Disease Control and Prevention (CDC), the Substance 
Abuse and Mental Health Services Administration (SAMSHA), as well as state and local public 
health agencies have made reducing prescription drug abuse a top priority (Centers for Disease 
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Control and Prevention, 2012a). In 2014, the 22 Association for State and Territorial Health 
Officials (ASTHO) implemented the 15x15 challenge that would reduce prescription drug 
misuse and deaths by 15% by 2015 (Association of State and Territorial Health Officers, 2014).  
In order for these organizations to meet their goals and combat the prescription drug abuse 
epidemic evidence-informed intervention strategies must be implemented at the state level. 
State-Level Intervention Strategies 
The U.S. prescription drug abuse epidemic has grown exponentially, which has 
significantly outpaced the ability to conduct significant research to inform and establish 
evidence-based practices to prevent prescription drug abuse (Levi et al., 2013). While research is 
ongoing to inform these important policy issues, the Prescription Drug Abuse Injury Policy 
Report published by Trust for America’s Health in collaboration with the Robert Wood Johnson 
Foundation identified 10 intervention strategies that were considered to be the most promising 
approaches to fighting prescription drug abuse.  These policies were identified through 
consultation with experts in public health, medicine and law enforcement.  Table 1 identifies and 
describes each of these 10 intervention strategies.    
The identified intervention strategies may be broken into two categories. The first 
category includes strategies aimed at prevention of drug misuse and abuse such as 
implementation and mandatory use of Prescription Drug Monitoring Programs (PDMPs), 
medical provider education laws, and implementation of physical exam requirements. The 
second category of interventions aims to increase access to and support for substance abuse 
services. These strategies include adoption of Good Samaritan laws, overdose harm reduction 
programs, and laws that support access to rescue drugs. This category also encourages resources 
be allocated for development and continued support for substance abuse services. Specifically, 
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the U.S. Department of Health and Human Services Substance Abuse and Mental Health 
Services Administration (SAMHSA) has reported a growing workforce crisis in the addictions 
field due to high turnover rates, worker shortages, an aging workforce, stigma and inadequate 
qualified workforce (Canady, 2015). 
Of the 10 intervention strategies outlined by Trust for America’s Health, two of them are 
not commonly employed in the vast majority of the states.  These two strategies are Good 
Samaritan laws and rescue drug laws. Good Samaritan laws are meant to encourage individuals 
to help someone in danger of an overdose by providing some degree of immunity from criminal 
charges or mitigation (Levi et al., 2013).  In fact, 88% of prescription painkiller users were more 
likely to call 911 after becoming aware of the Good Samaritan law in Washington (University of 
Washington Alcohol and Drug Abuse Institute, 2011). Rescue drug laws, on the other hand, are 
intended to support greater access to, and use of, naloxone for overdosing individuals given by 
lay responders. Naloxone (Narcan) is a rescue drug that counteracts the effects of an opioid or 
heroin drug overdose.  Although these Good Samaritan laws and rescue drug laws are promising, 
they were only enacted in 6 and 17 states, respectively (Table 1).  Policy initiatives that aim to 
curb prescription drug abuse across the country should focus on implementation of these two 
strategies as a large number of states have not yet established these policies.  This presents a 
prime opportunity to make remarkable strides in fighting the prescription drug abuse epidemic 
through policy initiatives at the state level.   
Prescription Drug Abuse in Indiana 
 In 2011, Indiana ranked 17th for drug overdose mortality in the United States and 
reported 14.4 drug overdose mortalities per 100,000 people (Levi et al., 2013). However, 
Indiana’s high ranking may not be a total surprise as thirty-three states throughout the U.S. had 
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implemented more intervention and prevention strategies than Indiana as of 2011 (Levi et al., 
2013).  Fortunately, Indiana state policymakers have worked diligently to expand Good 
Samaritan laws and rescue drug laws that may be vital to the prevention of prescription drug 
abuse in Indiana.  
Senate Bill 227: Expanding the Good Samaritan Law 
Indiana expanded the Good Samaritan law that provides immunity to first responders 
with SB 227, authored by Senator Jim Merritt.  This law went into effect in March of 2014. 
Through this legislation first responders are now allowed to utilize naloxone in cases of 
emergency. The act amends the existing law thereby allowing a paramedic, medical technician, 
firefighter, law enforcement officer, emergency medical responder, or a paramedic to administer 
naloxone to a person suffering from a drug overdose (National Alliance for Model State Drug 
Laws, 2014). The act also provides immunity to health care providers which prescribe naloxone 
and the pharmacists who dispense the prescription (National Alliance for Model State Drug 
Laws, 2014).  
With the expanded Good Samaritan law in Indiana, the Indianapolis Metro Police 
Department (IMPD) was able to implement a naloxone pilot program in their Southwest District.  
IMPD started this program in April of 2014. Shortly thereafter, IMPD expanded the naloxone 
program to all their districts, which has recorded 46 lives saved in Indianapolis (Fredrick, 2015).  
Other police departments throughout the State of Indiana have implemented similar programs as 
a result of IMPDs success.  These other programs have recorded saving an additional 86 lives as 
of January 2015 (Fredrick, 2015). State police departments have continued to demonstrate great 
success through these programs which were ultimately made possible through the adoption of 
expanded Good Samaritan laws in Indiana.  
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Additionally, SB 227 expanded the existing law to include Emergency Medical 
Technicians (EMTs) in the definition of first responders, which has led to the Emergency 
Medical System (EMS) in Indiana reporting increased number of naloxone administrations. EMS 
reports indicate that there were 629 administrations of naloxone in 2013, which jumped to 1,063 
administrations in 2014 (Duwve, 2015).  Furthermore, the average number of administrations per 
months in the first 6 months of 2014 was 52.4.  However, the number more than doubled in the 
second half of the year by increasing to 105.6 administrations per month (Duwve, 2015). These 
data indicate that naloxone use has increased since the adoption of SB 227.  As the usage of 
naloxone has increased in Indiana, toxicology reports also indicate that the number of deaths due 
to opioid overdose in Marion County decreased from 26 cases in June of 2014 to 12 cases in July 
of 2014 (B. Ray, personal communication, April 15, 2015).  Passage of SB 227 in Indiana was a 
positive step that has facilitated a reduction in opioid overdoses. However, additional policy 
initiatives in Indiana must strive to expand support for rescue drug laws to further reduce the 
impact of prescription drug abuse on Indiana residents across the state. 
Indiana Senate Bill 406: Rescue Drug Laws 
 The primary purpose of SB 227 was to expand Good Samaritan laws whereas, SB 406 
sought to support rescue drug laws to further expand naloxone administration by family 
members, friends and other individuals. More specifically SB 406 1) expands direct prescription-
based access to high-risk individuals and those closest to him or her, 2) requires emergency 
responders to report the number of times the antidote is administered, and 3) provides civil and 
criminal protections.  Naloxone has been called the ‘cousin of the EpiPen’ after being distributed 
safely to tens of thousands of private citizens in the Midwest. The Indiana Senate passed the bill 
50-0 in March of 2015. In April of 2015, the Indiana House Public Health Committee passed SB 
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406, which is very similar to pro-Naloxone legislation passed in other surrounding states. The 
bill passed by the House, and the Governor signed it into law upon his signature April 10, 2015.  
According to the CDC, “providing naloxone kits to laypersons reduces overdose deaths, 
is safe, and is cost-effective” (Wheeler, Jones, & Gilbert, 2015). Furthermore, many states, now 
including Indiana, have laws to support the distribution of naloxone to laypersons.  The number 
of organizations distributing naloxone is increasing.  However, in 2013, 20 states had no 
organization providing naloxone to laypersons(Wheeler et al., 2015). Indiana has now expanded 
legislation to support layperson administration of naloxone, but the successful implementation of 
these policies relies on continued work and commitment from public health professionals, law 
enforcement, policymakers and health professionals.   
The Role of Nursing in Successful Implementation of State Policy 
  In 2012, the Bureau of Health Workforce (BHW) in the Department of Health and 
Human Services (DHHS) reported that there were approximately 2.9 million registered nurses 
(RNs) actively practicing,(Health Resources and Services Administration, 2014) making RNs the 
largest component of the workforce in the health system.  Nurses are vital health care providers 
that play important roles in coordinated care efforts.  They are a major player in virtually all 
health care settings and their demand is increasing.  
  In Indiana, as a part of the requirements set forth by ratification of SB 227, law 
enforcement and first responders were given the charge of administering intra-nasal naloxone in 
opiate/heroin overdose cases after receiving appropriate education.  The tenants of the education 
included the pharmacokinetics and pharmacodynamics of opiates and naloxone, and recognition 
of an overdose presentation at the scene.  A pilot project was completed by one advanced 
practice nurse (APN) in fulfillment of her Doctorate education.  To extend evidenced based 
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practice as it relates to opiate/heroin substance abuse, overdose management, and 
epidemiological criminology, the hypothesis in the translation of the evidence into practice was 
that education would increase knowledge comprehension and improve officers’ attitudes toward 
administering intra-nasal naloxone to an overdose victim.  The Opioid Overdose Knowledge 
(OOKS) and Attitude (OOAS) scale (Williams, Strang, & Marsden, 2013) was utilized.   
          Training was provided to three rural county sheriff departments which included first 
responders and one university campus law enforcement agency.  IRB granted exempt status prior 
to the institution of the project.  The training consisted of didactic and skills competency training 
with return demonstration.  Pre and post-testing was employed.  Statistical analysis of the data 
collected showed knowledge improved pre to post testing thus impacting competency and 
concern scores as was anticipated.  Interestingly, readiness scores showed the officers 
resoundingly stated they would want to be able to help an overdose victim (100%), felt the need 
to intervene (96.7%), would call for an ambulance immediately (96.7%) and would do whatever 
necessary to save a life (90%) (Purviance & Southard, 2015).  Thus, this effort by nursing 
contributed to the advancement of the Theory of Epidemiological Criminology (Akers, Potter, & 
Hill, 2013), and added validity to the OOKS and OOAS as a tool for research.   
       From this research project, advanced practice nurses are being utilized by the Indiana 
Attorney General’s (AG’s) BitterPill Task force to disseminate education to law enforcement and 
first responders throughout the state.  A “train-the-trainer” project is being launched to provide 
an avenue to educate emergency services personnel, law enforcement on university and college 
campuses state wide, and through the Indiana Sheriff’s Association.  At the annual BitterPill 
symposium hosted by the AG’s office, a large scale “train-the-trainer” session will be provided 
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with coordination with the Indiana State Department of Health by a Doctorate of Nursing 
Practice prepared APN.    
       Nursing is well represented on the AG’s task force in a variety of settings.  Current efforts 
include exploring substance abuse and opiate pharmacology education for licensed and non-
licensed nursing personnel.  The charge is to develop a robust curriculum standard addressing 
substance abuse, risk stratification, early recognition of potential opiate addiction, and enhanced 
communication skills including interactive interviewing and conflict management.   Nursing is 
working to adopt or adapt patient education materials for the bedside nurse, meeting quality 
improvement benchmarks set by credentialing bodies, as well as evaluating current published 
materials to provide on the BitterPill website for public viewing.  And lastly, nurses are 
dialoging with the State Nursing Board in the adoption of opiate prescribing regulations, much 
like those enacted by the Indiana Medical Licensing Board ("Emergency Rule," 2013).   
       With the passage of Aaron’s Law (SB 406), one DNP prepared APN has been instrumental 
in the development of the Indiana Coalition of Prevention and Treatment, (ICPT), a non-profit 
organization. This coalition was founded in response to a grass root effort by parents and 
consumers throughout the state, representing those who have lost loved ones to opiate/heroin 
overdoses.  Education and political lobbying are the heart of the organization.  Out of these 
efforts, and those at the AG task force, education for family and friends is earmarked.  The hope 
of the nurses involved is to reach out to community and faith-based organizations to provide 
addiction, substance abuse, and naloxone education.   
Additionally, in 2015, the Substance Abuse and Mental Health Services Administration 
(SAMHSA) released a 5 point plan to improve the nation’s mental health.(Canady, 2015)  As a 
part of the 5 point plan, SAMHSA calls for an expansion of the mental health workforce that will 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
AC
CE
PT
ED
POLICY WATCH: RX ABUSE AND STATE POLICY 11 
 
meet the demands for mental health services. The nursing workforce is once again a critical 
component of these mental health workforce expansion efforts, as nurses may specialize in areas 
such as psychiatry/mental health and substance abuse.  Currently, approximately 4% of Indiana’s 
nursing workforce is specialized in these areas. As such, the State of Indiana, has capitalized on 
their versatility and clinical expertise to educate and train law enforcement and lay responders in 
the use and administration of naloxone as a result of the passage of SB 227 and SB 406. The 
nursing workforce has and will continue to play a critical role in the successful implementation 
of these state policy initiatives.    
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Conclusion 
The distribution of opioid drugs has increased by over 7 times between 1997 and 2007 
(Centers for Disease Control and Prevention, 2012a). Although the death rate associated with 
opioid pain relievers decreased from 2010 to 2012 (Rudd et al., 2014), prescription drug abuse 
and heroin use remains a significant problem in the United States. Prescription drug abuse is by 
no means a new problem in the United States.  However, the continued growth and the current 
scale of the problem have reason to raise serious concern (Compton, Thomas, Conway, & 
Colliver, 2005).  Research efforts will eventually catch up with the prescription drug abuse 
epidemic; however states must look to implement intervention and prevention strategies that are 
considered to be the most promising in fighting prescription drug abuse.  
As of 2011, Indiana had only implemented 5 of the 10 strategies recommended by Trust 
for America’s Health (Levi et al., 2013).   Since then, Indiana has expanded Good Samaritan 
laws and adopted rescue drug laws that promote the use of naloxone to prevent opioid and heroin 
drug overdoses.  Furthermore, Indiana has called on the nursing workforce to help train and 
educate first responders and lay persons in the administration of naloxone.  Indiana has had great 
success, in a short period of time, with the adoption of these new state policies.  In addition, 
nurses throughout the state have stepped up to help with implementation.  The contribution of the 
nursing workforce has been key to sustaining the momentum in Indiana and maximizing the 
impact these initiatives have on prescription drug abuse in Indiana. 
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Table 1: State Level Policy Indicators for Prescription Drug Abuse Prevention 
 
Indicator (Intervention) Description States with Intervention* 
Prescription Drug Monitoring Programs Does the state have an operational Prescription 
Drug Monitoring Program? 49 
Mandatory Use of PDMP Does the state require mandatory use of PDMPs 
by providers? 16 
Doctor Shopping Laws Does the state have a doctor shopping statute? 50 
Support for Substance Abuse Services Has the state expanded Medicaid under the 
Affordable Care Act, thereby expanding 
coverage of substance abuse treatment? 
24 
Medical Provider Education Laws Does the state require or recommend education 
for prescribers of pain medications? 22 
Good Samaritan Laws Does the state have a law in place to provide a 
degree of immunity from criminal charges for an 
individual seeking help for themselves or others 
experiencing an overdose? 
6 
Rescue Drug Laws Does the state have a law in place to expand 
access to, and use of, naloxone for overdosing 
individuals given by lay administrators? 
17 
Physical Exam Requirement Does the state require a healthcare provider to 
either conduct a physical exam of the patient 
prior to prescribing prescription medications? 
44 
ID Requirement Does the state have a law requiring or 
permitting a pharmacist to ask for identification 
prior to dispensing a controlled substance? 
32 
Pharmacy Lock-In Program Does the state’s Medicaid plan have a pharmacy 
lock-in program that requires individuals 
suspected of misusing controlled substances to 
use a single prescriber and pharmacy? 
46 
*These are the number of states that have implemented these interventions as of 2011 
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